Imagene AI has entered into a collaboration with Daiichi Sankyo to advance biomarker discovery and response prediction across oncology drug development programs
Under the collaboration, Daiichi Sankyo will leverage Imagene’s OI Suite, powered by the CanvOI foundation model, to integrate H&E and IHC whole-slide images with molecular and clinical data to enhance biomarker identification and…
Abstract
Just like the Internet in 1990’s, Artificial intelligence is now changing all aspects of our life and work. It’s impact is beginning to show in the industry and it is changing the life-sciences practice by fundamentally altering the way how medicines are discovered, developed, manufactured, approved, supplied and brought to market.
In research and discovery, generative models and structure prediction systems shorten the path from target to lead and raise the ceiling…
Shots:
Welcome to the October edition of Know Your Investor, spotlighting leading investors shaping the future of healthcare and life sciences
This month, we feature Google Ventures (GV), the venture capital arm of Alphabet. GV actively invests across seed to growth-stage companies, spanning sectors such as software, internet, healthcare, life sciences, and artificial intelligence
For…
Day 1 Breakdown
The #PCG2025 Symposium commenced on an inspiring note, setting the stage for two days of insightful discussions, collaborations, and knowledge exchange.
Opening Session
Dr. Ratnesh Jain, Founder & Director, Mumbai Cluster, delivered the inaugural address, sharing his vision of bringing together pharma professionals, R&D experts, CXOs, and academicians to accelerate advancements in…
The peptide therapeutics market in North America and beyond is evolving fast, and 2025 is set to be a groundbreaking year.
Whether you’re a researcher involved in peptide drug clinical trials, an investor in different pharmaceutical companies, or just curious about the future of medicine and drug discovery, understanding various peptide therapeutics market trends will…
We are now halfway through 2025, and it’s not too late to highlight the practices and trends that are shaping and will continue to shape the biopharma landscape this year. In 2024, we navigated the 4 biopharma trends that exerted vehement force in the industry and shaped the course of healthcare practices. Last year, the…
EVERYONE has a heroic story to tell, their own legend to fulfill and HLTH is forging ahead into new realms of possibilities, gathering 12,000+ influential leaders, executives and visionaries who are passionately creating the next generation of healthcare. At HLTH you can foster meaningful connections, gain insights on cutting-edge trends, enhance your professional journey, or…
In the CXO Talks podcast, PharmaShots engaged in a riveting dialogue exchange with Colin Banas, Chief Medical Officer at DrFirst. Colin highlights the evolution of DrFirst from becoming a leader in the e-prescribing space to an end-to-end medication management company
Colin talks about its collaborators, Wise Hospice Options, achieving a new milestone by reducing the…
Kamya Elawadhi joins PharmaShots’ Managing Editor Himanshu Sehgal in a riveting conversation before Reuters Pharma 2025, where she will be presenting a case study on the topic “Hack the Algorithm: Engage and Educate in the Digital and Omnichannel Age”
Kamya shares her opinion on the evolution of AI in revolutionizing the content in the healthcare…
Mental health treatment has long followed a one-size-fits-all approach, with clinicians often relying on trial and error to find effective medications and therapies. However, the landscape is rapidly changing as personalized medicine emerges at the forefront of psychiatric care and addiction treatment. By integrating genetic insights, artificial intelligence, and digital health technologies, healthcare providers are…

